Actively Recruiting
Micro-dosing Indocyanine Green (ICG) in Children
Led by Great Ormond Street Hospital for Children NHS Foundation Trust · Updated on 2024-05-20
90
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this cohort study is to identify the lowest dose of Indocyanine Green (ICG) that achieves satisfactory intra-operative fluorescence for the assessment of gastrointestinal or genitourinary tract perfusion in children.
CONDITIONS
Official Title
Micro-dosing Indocyanine Green (ICG) in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged ≤18 years of age
- Elective surgery including gastrointestinal or genitourinary tract perfusion assessment
You will not qualify if you...
- Renal and liver dysfunction
- Active infection
- Coagulopathy
- Complex congenital heart defect
- Previous documented allergy to ICG injection or other iodinated contrast agents
- Patients suffering from hyperthyroidism or autonomic thyroid adenomas
- Premature infants or neonates in whom exchange transfusion is indicated, due to the hyperbilirubinaemia risk
- Concurrent use of sodium bisulphite-containing preparations, such as certain heparin preparations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Great Ormond Street Hospital for Children
London, United Kingdom, WC1N 3JH
Actively Recruiting
Research Team
S
Stefano Giuliani
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here